Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanne Roth

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Nature Reviews. Disease Primers|May 7, 2026
Pancreatic cancerSusanne Roth, Minoti Apte, Vinod P Balachandran, et al.
Journal of Hematology & Oncology|February 4, 2023
Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinomaYi Han, Pascal Drobisch, Alexander Krüger, et al.
Gut|September 21, 2016
Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancyBo Kong, Philipp Bruns, Nora A Behler, et al.
Gastroenterology|June 1, 2023
Spatially Resolved Multi-Omics Single-Cell Analyses Inform Mechanisms of Immune Dysfunction in Pancreatic CancerSuhail Yousuf, Mengjie Qiu, Lena Voith von Voithenberg, et al.
Cell Reports. Medicine|February 6, 2025
Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapyHongzhen Li, Zhiheng Zhang, Zhao Shi, et al.
Neuroendocrinology|April 26, 2022
Genetically Determined Telomere Length Is Associated with Pancreatic Neuroendocrine Neoplasms OnsetManuel Gentiluomo, Gabriele Capurso, Luca Morelli, et al.
Nature Communications|April 15, 2026
Spliceosome induction is a druggable dependency of RAS-driven senescence and cancerVerena Wagner, Laura Bousset, Mariana Ascensão-Ferreira, et al.
Translational Oncology|September 1, 2024
Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic responseJingyu An, Roma Kurilov, Teresa Peccerella, et al.
Nature Medicine|May 21, 2021
XCR1<sup>+</sup> type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitisAleksandra Deczkowska, Eyal David, Pierluigi Ramadori, et al.
Oncogene|August 8, 2025
ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer networkXiaoping Zou, Shuang Nie, Jing Cao, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Nature Reviews. Disease Primers|May 7, 2026
Pancreatic cancerSusanne Roth, Minoti Apte, Vinod P Balachandran, et al.
Journal of Hematology & Oncology|February 4, 2023
Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinomaYi Han, Pascal Drobisch, Alexander Krüger, et al.
Gut|September 21, 2016
Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancyBo Kong, Philipp Bruns, Nora A Behler, et al.
Gastroenterology|June 1, 2023
Spatially Resolved Multi-Omics Single-Cell Analyses Inform Mechanisms of Immune Dysfunction in Pancreatic CancerSuhail Yousuf, Mengjie Qiu, Lena Voith von Voithenberg, et al.
Cell Reports. Medicine|February 6, 2025
Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapyHongzhen Li, Zhiheng Zhang, Zhao Shi, et al.
Neuroendocrinology|April 26, 2022
Genetically Determined Telomere Length Is Associated with Pancreatic Neuroendocrine Neoplasms OnsetManuel Gentiluomo, Gabriele Capurso, Luca Morelli, et al.
Nature Communications|April 15, 2026
Spliceosome induction is a druggable dependency of RAS-driven senescence and cancerVerena Wagner, Laura Bousset, Mariana Ascensão-Ferreira, et al.
Translational Oncology|September 1, 2024
Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic responseJingyu An, Roma Kurilov, Teresa Peccerella, et al.
Nature Medicine|May 21, 2021
XCR1<sup>+</sup> type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitisAleksandra Deczkowska, Eyal David, Pierluigi Ramadori, et al.
Oncogene|August 8, 2025
ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer networkXiaoping Zou, Shuang Nie, Jing Cao, et al.
Pageof 8